Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study
BackgroundEffective blood pressure (BP) control is vital for preventing target organ damage, and combination therapy offers added benefits when single-agent treatment is insufficient. This cohort study examined whether Telminuvo, a single-pill combination of telmisartan and S-amlodipine, effectively maintains kidney function as a target organ in a large cohort of Korean patients.MethodsA total of 4,934 patients from 30 hospitals were treated with Telminuvo for over six months, with BP, estimated glomerular filtration rate (eGFR), electrolyte levels, and adverse events monitored throughout the study period.ResultsAmong the participants, 1,463 (29.7%) used Telminuvo for less than 1 year, while the remainder used it for longer. At baseline, the systolic and diastolic BP averaged 140.2 ± 18.4 mmHg and 82.1 ± 13.4 mmHg, respectively, which significantly decreased to approximately 130 and 75 mmHg after the initiation of treatment. The baseline eGFR of 79.3 mL/min/1.73 m2 remained stable over three years, regardless of the initial eGFR levels. Within the first six months, acute kidney injury (defined as either a ≥ 0.3 mg/dL increase in serum creatinine or a ≥ 50% increase from baseline) occurred in 6.6% of patients, while hyperkalemia (defined as serum potassium levels > 5.5 mmol/L) was observed in 3.2% of patients.ConclusionThis cohort study demonstrates that Telminuvo effectively reduces blood pressure without compromising kidney function. Furthermore, the findings provide additional insights into drug-related adverse events, which will be valuable for clinicians in the real-world prescribing of Telminuvo.
36
- 10.1016/j.mcna.2009.02.003
- May 1, 2009
- Medical Clinics of North America
369
- 10.1053/j.ajkd.2003.09.026
- Jan 1, 2004
- American Journal of Kidney Diseases
36
- 10.1038/hr.2016.183
- Jan 26, 2017
- Hypertension Research
16
- 10.23876/j.krcp.2018.37.1.49
- Mar 31, 2018
- Kidney Research and Clinical Practice
3
- 10.7759/cureus.41398
- Jul 5, 2023
- Cureus
638
- 10.1097/hjh.0000000000002453
- Jun 1, 2020
- Journal of Hypertension
241
- 10.1038/s41569-020-00437-9
- Oct 9, 2020
- Nature Reviews Cardiology
183
- 10.7326/0003-4819-151-1-200907070-00122
- May 18, 2009
- Annals of Internal Medicine
34
- 10.1016/j.mcna.2009.02.005
- May 1, 2009
- Medical Clinics of North America
2516
- 10.1038/s41581-019-0244-2
- Feb 5, 2020
- Nature Reviews Nephrology
- Research Article
125
- 10.1038/ki.2011.119
- Aug 1, 2011
- Kidney International
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- Front Matter
34
- 10.1016/j.jhep.2013.05.035
- May 31, 2013
- Journal of Hepatology
Acute kidney injury (AKI) in cirrhosis: Should we change current definition and diagnostic criteria of renal failure in cirrhosis?
- Research Article
620
- 10.1038/sj.ki.5001527
- Jul 1, 2006
- Kidney International
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery
- Front Matter
178
- 10.1053/j.ajkd.2007.05.008
- Jul 1, 2007
- American Journal of Kidney Diseases
Improving Outcomes From Acute Kidney Injury: Report of an Initiative
- Research Article
50
- 10.1038/ki.2012.227
- Oct 1, 2012
- Kidney International
Oral bisphosphonate use in the elderly is not associated with acute kidney injury
- Research Article
14
- 10.1542/pir.35.1.30
- Jan 1, 2014
- Pediatrics In Review
Acute Kidney Injury
- Research Article
17
- 10.1542/pir.35-1-30
- Jan 1, 2014
- Pediatrics in Review
1. David T. Selewski, MD* 2. Jordan M. Symons, MD† 1. *Department of Pediatrics and Communicable Diseases, Division of Nephrology, C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI. 2. †Department of Pediatrics, Division of Nephrology, University of Washington School of Medicine, Seattle, WA. * Abbreviations: ACE: : angiotensin-converting enzyme AKI: : acute kidney injury AKIN: : Acute Kidney Injury Network ANCA: : antineutrophil cytoplasmic antibody ATN: : acute tubular necrosis ECG: : electrocardiogram FEurea: : fractional excretion of urea FENa: : fractional excretion of sodium KDIGO: : Kidney Disease: Improving Global Outcomes NSAID: : nonsteroidal anti-inflammatory drug RIFLE: : Risk, Injury, Failure, Loss, and End-stage The term acute kidney injury has replaced acute renal failure and represents a spectrum of clinically meaningful kidney damage. After completing this article, readers should be able to: 1. Recognize and define the spectrum of acute kidney injury (AKI). 2. Understand the diagnostic approach and be able to differentiate the main causes of AKI. 3. Understand the complications of AKI and the treatment of a child with AKI. Acute kidney injury (AKI), formerly called acute renal failure, is characterized by multiple abnormalities, including increases in serum creatinine and blood urea nitrogen, electrolyte abnormalities, acidosis, and difficulties with fluid management. We have come to realize that what was previously thought to be relatively minor damage to the kidney can have significant short-term effects on morbidity and mortality and potential long-term implications for the development of chronic kidney disease. Thus, the term acute kidney injury has replaced acute renal failure , suggesting the spectrum of kidney damage that can occur. ### Definition AKI is classically defined as an acute decrease in glomerular filtration rate, which results in an increase in serum creatinine. It is important to recognize the limitations of creatinine as a marker of AKI because an increase in creatinine can be delayed by as much as 48 hours after damage to the kidney has occurred. Despite this limitation, change in creatinine remains the gold standard for the diagnosis of AKI. An evolution in the definition of AKI to better understand, characterize, and study the disease spectrum, has occurred, which has sought to capture the clinical importance of even small variations in kidney function. In addition, previous definitions used in the literature were widely disparate; this …
- Front Matter
77
- 10.1053/j.ajkd.2008.07.008
- Aug 23, 2008
- American Journal of Kidney Diseases
NGAL in Acute Kidney Injury: From Serendipity to Utility
- Research Article
147
- 10.1002/lt.21877
- Oct 28, 2009
- Liver Transplantation
Michael R. Charlton, William J. Wall, Akinlolu O. Ojo, Pere Gines, Stephen Textor, Fuad S. Shihab, Paul Marotta, Marcelo Cantarovich, James D. Eason, Russell H. Wiesner, Michael A. Ramsay, Juan C. Garcia-Valdecasas, James M. Neuberger, Sandy Feng, Connie L. Davis, Thomas A. Gonwa, and the International Liver Transplantation Society Expert Panel Mayo Clinic, Rochester MN; Department of General Surgery, London Health Science Center, London, Ontario, Canada; Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI; Liver Unit, Hospital Clinic, University of Barcelona School of Medicine, Barcelona, Spain; Department of Nephrology, University of Utah School of Medicine, Salt Lake City, UT; Medical School, University of Western Ontario, London, Ontario, Canada; Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada; Transplant Institute, University of Tennessee, Memphis, TN; Baylor University Medical Center, Dallas, TX; Hospital Clinic I Provincial, Barcelona, Spain; Queen Elizabeth Hospital, Birmingham, England; Department of Transplant Surgery, University of California San Francisco Medical Center, San Francisco, CA; Department of Medicine, University of Washington Medical Center, Seattle, WA; and Mayo Clinic, Jacksonville, FL
- Research Article
53
- 10.1016/j.jhep.2010.12.001
- Dec 9, 2010
- Journal of Hepatology
Immunosuppression in liver transplant recipients with renal impairment
- Front Matter
5
- 10.2217/bmm.14.89
- Dec 1, 2014
- Biomarkers in Medicine
Novel biomarkers of acute kidney injury: time for implementation?
- Front Matter
30
- 10.1053/j.ajkd.2007.12.004
- Feb 1, 2008
- American Journal of Kidney Diseases
Multimodality Prevention of Contrast-Induced Acute Kidney Injury
- Research Article
161
- 10.1053/j.ackd.2012.10.003
- Dec 22, 2012
- Advances in Chronic Kidney Disease
Perioperative Acute Kidney Injury
- Research Article
45
- 10.1053/j.ackd.2008.04.007
- Jun 17, 2008
- Advances in chronic kidney disease
Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective
- Research Article
39
- 10.1016/j.bbmt.2010.07.010
- Jul 22, 2010
- Biology of Blood and Marrow Transplantation
Pretransplant Predictors and Posttransplant Sequels of Acute Kidney Injury after Allogeneic Stem Cell Transplantation
- Research Article
- 10.5049/ebp.2025.23.e3
- Jun 1, 2025
- Electrolytes & Blood Pressure : E & BP
- Research Article
- 10.5049/ebp.2025.23.e2
- Jun 1, 2025
- Electrolytes & Blood Pressure : E & BP
- Research Article
- 10.5049/ebp.2025.23.e1
- May 8, 2025
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
8
- 10.5049/ebp.2022.20.2.64
- Dec 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
- 10.5049/ebp.2022.20.2.49
- Dec 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
- 10.5049/ebp.2022.20.2.57
- Dec 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Research Article
2
- 10.5049/ebp.2022.20.1.17
- Jun 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
14
- 10.5049/ebp.2022.20.1.1
- Jun 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
5
- 10.5049/ebp.2022.20.1.21
- Jun 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Supplementary Content
2
- 10.5049/ebp.2022.20.1.10
- Jun 1, 2022
- Electrolytes & Blood Pressure : E & BP
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.